These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 19879258

  • 1. Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma.
    Cheng Y, Zhang C, Zhao J, Wang C, Xu Y, Han Z, Jiang G, Guo X, Li R, Bu X, Wu M, Wei L.
    Exp Mol Pathol; 2010 Feb; 88(1):112-7. PubMed ID: 19879258
    [Abstract] [Full Text] [Related]

  • 2. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma.
    Zhang C, Li Z, Cheng Y, Jia F, Li R, Wu M, Li K, Wei L.
    Clin Cancer Res; 2007 Feb 01; 13(3):944-52. PubMed ID: 17289889
    [Abstract] [Full Text] [Related]

  • 3. CpG island methylator phenotype associated with tumor recurrence in tumor-node-metastasis stage I hepatocellular carcinoma.
    Li B, Liu W, Wang L, Li M, Wang J, Huang L, Huang P, Yuan Y.
    Ann Surg Oncol; 2010 Jul 01; 17(7):1917-26. PubMed ID: 20112070
    [Abstract] [Full Text] [Related]

  • 4. [Correlations of CpG island methylator phenotype and OPCML gene methylation to carcinogenesis of hepatocellular carcinoma].
    Liu WJ, Wang L, Wang JP, Li JQ, Zhang CQ, Zheng L, Yuan YF.
    Ai Zheng; 2006 Jun 01; 25(6):696-700. PubMed ID: 16764763
    [Abstract] [Full Text] [Related]

  • 5. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B, Ma Y, Wu G, Tong X, Guo H, Liang A, Cong W, Liu C, Wang H, Wu M, Zhao J, Guo Y.
    Clin Cancer Res; 2008 Nov 15; 14(22):7405-12. PubMed ID: 19010857
    [Abstract] [Full Text] [Related]

  • 6. CpG island methylation status in gastric carcinoma with and without infection of Epstein-Barr virus.
    Chang MS, Uozaki H, Chong JM, Ushiku T, Sakuma K, Ishikawa S, Hino R, Barua RR, Iwasaki Y, Arai K, Fujii H, Nagai H, Fukayama M.
    Clin Cancer Res; 2006 May 15; 12(10):2995-3002. PubMed ID: 16707594
    [Abstract] [Full Text] [Related]

  • 7. CpG island methylator phenotype involving tumor suppressor genes located on chromosome 3p in non-small cell lung cancer.
    Liu Z, Zhao J, Chen XF, Li W, Liu R, Lei Z, Liu X, Peng X, Xu K, Chen J, Liu H, Zhou QH, Zhang HT.
    Lung Cancer; 2008 Oct 15; 62(1):15-22. PubMed ID: 18358560
    [Abstract] [Full Text] [Related]

  • 8. CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma.
    Zhang C, Guo X, Jiang G, Zhang L, Yang Y, Shen F, Wu M, Wei L.
    Int J Cancer; 2008 Sep 01; 123(5):998-1004. PubMed ID: 18546260
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor-containing fibulin-like extracellular matrix protein 1, EFEMP1, a novel tumor-suppressor gene detected in hepatocellular carcinoma using double combination array analysis.
    Nomoto S, Kanda M, Okamura Y, Nishikawa Y, Qiyong L, Fujii T, Sugimoto H, Takeda S, Nakao A.
    Ann Surg Oncol; 2010 Mar 01; 17(3):923-32. PubMed ID: 19898900
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Accumulation of DNA methylation is associated with tumor stage in gastric cancer.
    Oue N, Mitani Y, Motoshita J, Matsumura S, Yoshida K, Kuniyasu H, Nakayama H, Yasui W.
    Cancer; 2006 Mar 15; 106(6):1250-9. PubMed ID: 16475210
    [Abstract] [Full Text] [Related]

  • 12. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus.
    Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, Hosokawa M, Shinomura Y, Imai K, Tokino T.
    Cancer; 2006 Apr 01; 106(7):1467-79. PubMed ID: 16518809
    [Abstract] [Full Text] [Related]

  • 13. The CpG island methylator phenotype correlates with long-range epigenetic silencing in colorectal cancer.
    Karpinski P, Ramsey D, Grzebieniak Z, Sasiadek MM, Blin N.
    Mol Cancer Res; 2008 Apr 01; 6(4):585-91. PubMed ID: 18403637
    [Abstract] [Full Text] [Related]

  • 14. Abnormal expression of hepatoma specific gamma-glutamyl transferase and alteration of gamma-glutamyl transferase gene methylation status in patients with hepatocellular carcinoma.
    Yao D, Jiang D, Huang Z, Lu J, Tao Q, Yu Z, Meng X.
    Cancer; 2000 Feb 15; 88(4):761-9. PubMed ID: 10679644
    [Abstract] [Full Text] [Related]

  • 15. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma.
    Zhang YJ, Ahsan H, Chen Y, Lunn RM, Wang LY, Chen SY, Lee PH, Chen CJ, Santella RM.
    Mol Carcinog; 2002 Oct 15; 35(2):85-92. PubMed ID: 12325038
    [Abstract] [Full Text] [Related]

  • 16. Prognostic implications of and relationship between CpG island hypermethylation and repetitive DNA hypomethylation in hepatocellular carcinoma.
    Lee HS, Kim BH, Cho NY, Yoo EJ, Choi M, Shin SH, Jang JJ, Suh KS, Kim YS, Kang GH.
    Clin Cancer Res; 2009 Feb 01; 15(3):812-20. PubMed ID: 19188151
    [Abstract] [Full Text] [Related]

  • 17. Frequent hypermethylation of CpG islands and loss of expression of the 14-3-3 sigma gene in human hepatocellular carcinoma.
    Iwata N, Yamamoto H, Sasaki S, Itoh F, Suzuki H, Kikuchi T, Kaneto H, Iku S, Ozeki I, Karino Y, Satoh T, Toyota J, Satoh M, Endo T, Imai K.
    Oncogene; 2000 Nov 02; 19(46):5298-302. PubMed ID: 11077447
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of CpG island methylator phenotype among hepatocellular carcinoma patients: A systematic review and meta-analysis.
    Wang Q, Wang G, Liu C, He X.
    Int J Surg; 2018 Jun 02; 54(Pt A):92-99. PubMed ID: 29698791
    [Abstract] [Full Text] [Related]

  • 19. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search.
    Moribe T, Iizuka N, Miura T, Stark M, Tamatsukuri S, Ishitsuka H, Hamamoto Y, Sakamoto K, Tamesa T, Oka M.
    Int J Oncol; 2008 Nov 02; 33(5):949-58. PubMed ID: 18949357
    [Abstract] [Full Text] [Related]

  • 20. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma.
    Yeo W, Wong N, Wong WL, Lai PB, Zhong S, Johnson PJ.
    Liver Int; 2005 Apr 02; 25(2):266-72. PubMed ID: 15780049
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.